IGF2 and neoplasm: Birthweight is likely a marker for intrauterine levels of sex estrogen and progesterone, growth hormone, IGF-1, IGF-2, and insulin itself which may increase the number of susceptible stem cells in the mammary gland or enhance cell proliferation, thereby contributing to tumor development through accumulation of DNA mutations8.